McKesson gets $400M Dept of Defense PACS contract

Nicholas Leider | | Health Imaging | Enterprise Imaging

According to a Jan. 4 release from the Department of Defense, McKesson Technologies has been awarded a $400 million contract for digital imaging network PACS products and maintenance.

The Atlanta Business Chronicle reported the $400 million figure is for the full life of the five-year base contract with another five-year option period. The performance completion date is Dec. 15, 2027. 

For more, click below:

McKesson Technologies in Alpharetta awarded $400M DOD health imaging contract

""
Nicholas Leider, Managing Editor

Nicholas joined TriMed in 2016 as the managing editor of the Chicago office. After receiving his master’s from Roosevelt University, he worked in various writing/editing roles for magazines ranging in topic from billiards to metallurgy. Currently on Chicago’s north side, Nicholas keeps busy by running, reading and talking to his two cats.

Related Content

Chinese hackers use malware disguised as imaging viewers to steal patient data
Newly launched report feature provides patients with a visual aid to their imaging
Sectra and Siemens Healthineers partner to improve CT workflows
GE HealthCare taps Enlitic for large-scale imaging data migration plans
Top performing PACS companies based on user feedback
Enterprise imaging expands in smaller and midsized hospitals

Around the web

Cardiovascular Business
ASE updates recommendations for assessing right heart function in patients with pulmonary hypertension

The new guidelines were designed to ensure sonographers and other members of the heart team have the information they need to screen patients when appropriate and identify early warnings signs of PH. 

Radiology Business
Shift toward imaging outside the hospital could save billions

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

Cardiovascular Business
‘A significant milestone’: First US patients receive doses of new PET radiotracer for CAD

Back in September, the FDA approved GE HealthCare’s new PET radiotracer, flurpiridaz F-18, for patients with known or suspected CAD. It is seen by many in the industry as a major step forward in patient care.